Table 1.
I | Quiescent stage: 2-month HIP model |
No obvious microcirculation remodeling as compared to the SDC model. | |
Loss of desmosomes and adherens junctions associated with widening of the islet exocrine interface. | |
II | Islet wounding stage: 4-month HIP model |
Pericapillary islet amyloid deposition, islet amyloid deposition between the pericyte and endothelial cell of the microcirculation, strongest signal for α-SMA antibody positive staining of pericytes and pericyte hyperplasia and/or migration to the islet exocrine interface. | |
III | Pericyte and β-cell apoptosis stage: 8-month HIP model |
Pericyte and β-cell apoptosis, progressive migration and or hyperplasia of pericytes | |
in the islet exocrine interface. Endocrine islet cell invasion of the exocrine extracellular matrix. | |
IV | Cellular - Pericyte differentiation stage: 14-month HIP model |
Adipogenesis, collagenosis and angiogenesis | |
The islet microcirculation paradox: consisting of intra-islet capillary rarefaction occurring contemporaneously with islet exocrine interface angiogenesis. | |
Each of the above seems to be strongly associated with the pericyte. |
HIP, human islet amyloid polypeptide; T2DM, type 2 diabetes mellitus.